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Abstract  
The placenta accreta spectrum (PAS) is a complex obstetric complication associated 
with a high maternal morbidity. It is a relatively new disorder of placentation, and is the 
consequence of damage to the endometrium-myometrial interface of the uterine wall. 
When first described 80 years ago, it mainly occurred after manual removal of the 
placenta, uterine curettage or endometritis. Superficial damage leads primarily to an 
abnormally adherent placenta, and is diagnosed as the complete or partial absence of 
the decidua on histology. Today, the main cause of PAS is uterine surgery and, in 
particular, the uterine scar secondary to a caesarean delivery. In the absence of 
endometrial re-epithelialization of the scar area the trophoblast and villous tissue can 
invade deeply within the myometrium, including its circulation, and reach the 
surrounding pelvic organs. The cellular changes in the trophoblast observed in PAS are 
probably secondary to the unusual myometrial environment in which it develops, and 
not to a primary defect of trophoblast biology leading to excessive invasion of the 
myometrium. PAS was separated by pathologists into three categories: placenta creta 
(PC) when the villi simply adhere to the myometrium, placenta increta (PI) when the villi 
invade the myometrium, and placenta percreta (PP) where the villi invade the full 
thickness of the myometrium. Several prenatal ultrasound signs of PAS have been 
reported over the last 35 years, principally the disappearance of the normal utero-
placental interface (clear zone), extreme thinning of the underlying myometrium and 
vascular changes within the placenta (lacunae) and placental bed (hypervascularity). 
The pathophysiological basis of these signs is due to permanent damage of the uterine 
wall as far as the serosa, with placental tissue reaching the deep uterine circulation. 
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Adherent and invasive placentation may co-exist in the same placental bed and evolve 
with advancing gestation. This may explain why no single, or set combination of, 
ultrasound sign(s) has been found to be specific for the depth of abnormal placentation, 
and accurate for the differential diagnosis between adherent and invasive placentation. 
Correlation of pathological and clinical findings with the prenatal imaging is essential to 
improve screening, diagnosis and management of PAS, and standardised protocols 
need to be developed. 
 
 
 
Key Words: Placenta accreta; increta; percreta; ultrasound imaging; caesarean 
delivery; prenatal diagnosis. 
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INTRODUCTION  
The first case series of placenta accreta (PA) was published in 1937 by Irving and 
Hertig.1 They reviewed 18 cases, which they described clinically as “the abnormal 
adherence of the afterbirth in whole or in parts to the underlying uterine wall” and 
histologically as “the complete or partial absence of the decidua basalis”, signs that are 
still used today. They described all their cases as “vera” or “adherenta” where the villi 
were attached to the surface of the myometrium without invading it.  
 The grading classification of PA according to the depth of villous invasiveness 
inside the myometrium was introduced by modern pathologists in the 1960s.2-4 They 
separated PA into three categories: placenta creta (PC) when the villi simply adhere to 
the myometrium, placenta increta (PI) when the villi invade the myometrium and 
placenta percreta (PP) where the villi invade the full thickness of the myometrium 
(Figure 1). This terminology is still used by most pathologists. It is, however, often 
impossible to clinically differentiate between these categories, especially as they may 
co-exist in the same placental bed (Figure 2), and confusion frequently occurs amongst 
clinicians regarding the difference between the terms ‘accreta’ and ‘creta’. Given the 
lack of international consensus on nomenclature, for the purposes of this paper, we 
have chosen to refer to it as the placenta accreta spectrum (PAS), which includes both 
abnormal adherence and abnormal invasion. We will then use placenta creta (PC), 
increta (PI) and percreta (PP) for specific examples where the histology is known. 
In PAS, the lack of a plane of cleavage between the placental basal plate and the 
uterine wall leads to major hemorrhage if an attempt is made to forcibly remove villous 
tissue embedded within the myometrium.5-8 The severity of the complications varies 
 5 
according to the depth of villous invasion. In PP, not only is there potential villous 
invasion of surrounding pelvic organs, but excessive neovascularity is often present 
making any surgical procedure technically difficult. Multi-disciplinary team working and 
operator experience has been shown to reduce collateral damage, with several studies 
demonstrating that maternal morbidity is significantly reduced by delivery in a specialist 
centre.9-12 Thus, the prenatal diagnosis of PAS has become essential to its 
management and outcome. The first prenatal diagnosis of PAS was reported in 1967 by 
Sadovsky et al using radioisotope placentography13, and the first prenatal ultrasound 
description was made by Tabsh et al14 in 1982.  
Ultrasound imaging and magnetic resonance imaging (MRI) are now commonly 
used for the prenatal diagnosis of PAS.15-18 However, recent population studies have 
indicated that it remains undiagnosed before delivery in between half19,20 and two-thirds 
of cases.21 The cost and limited access of MRI make it impractical as a screening tool, 
and ultrasound has therefore become essential in identifying women at high risks of 
PAS and tailoring their management. Although many ultrasound diagnostic signs have 
been described, wide heterogeneity in both study design and terminology used by 
different authors has made it difficult to define the ultrasound markers that enable the 
different grades of villous adhesion or invasion to be distinguished.18 In this review, we 
have evaluated the pathophysiology of the different ultrasound signs associated with the 
PAS to better understand their relevance to the prenatal screening and diagnosis of 
accreta placentation. 
 
PATHOPHYSIOLOGY OF THE PLACENTA ACCRETA SPECTRUM 
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Several concepts have been proposed to explain why and how PAS occurs. The oldest 
concept is based on a theoretical primary defect of trophoblast biology leading to 
excessive invasion of the myometrium. The current prevailing hypothesis is that a 
secondary defect of the endometrium-myometrial interface leads to a failure of normal 
decidualisation in the area of a uterine scar, allowing abnormally deep placental 
anchoring villi and trophoblast infiltration.5 There is no doubt that the decidua normally 
regulates trophoblast invasion, as evidenced by the aggressive invasion of the muscular 
and serosal layers seen at sites of ectopic implantation in the Fallopian tube22 or in the 
abdomen.23  
 
Scar implantation 
During the secretory phase of the menstrual cycle, the endometrium transforms into a 
well-vascularised receptive tissue, which is characterised by the proliferation and 
differentiation of the stromal cells into decidual cells, the infiltration of maternal immune 
cells and vascular remodelling of the endometrial vessels.24,25 Decidualisation of the 
endometrium stroma precedes blastocyst attachment and trophoblast infiltration. The 
process is complex and involves many local uterine components and external maternal 
cells and hormones. It is essential for implantation and normal placental development.  
 The development of PAS has been mainly linked to surgical damage, which 
disrupts the integrity of the uterine endometrium and smooth muscle layers of the 
myometrium. The increased use of caesarean delivery (CD) has had a direct effect on 
the incidence of all grades of accreta placentation, but cases have been described 
following smaller and more superficial damage to the uterine wall such as that 
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associated with uterine curettage, manual removal of the placenta or post-partum 
endometritis.1,3-5 Cases of PAS have even been described in primigravida women with 
no surgical history, but presenting with a uterine pathology such as bicornuate uterus, 
adenomyosis, submucous fibroids or myotonic dystrophy.3-5 These latter cases suggest 
that microscopic defects of the endometrium or interferences with its normal biological 
functions may lead to abnormal villous tissue adhesion or even invasion. 
A uterine scar may range from a small defect of the decidua and superficial 
myometrium to a wide and deep defect of the myometrium with clear loss of substance 
from the endometrial cavity down to the uterine serosa.26 In women with a history of 
prior CD, scar defects have been found to range between 20% and 65% of the 
myometrium after delivery on transvaginal ultrasound. Women with a residual 
myometrial thickness of <50% of the adjacent myometrium are more likely to develop 
chronic complications such as inter-menstrual spotting.27 The myometrial fibres around 
a scar often show hyalinisation or degenerative changes, with a local increase in fibrous 
tissue and infiltration by inflammatory cells.3 The comparison of ultrasound features of 
uterine caesarean scar with histological findings has shown that large and deep 
myometrial defects are often associated with absence of re-epithelialisation of the scar 
area.28 Leucocyte recruitment to the endometrium during the secretory phase may also 
be affected by the presence of a CD scar. A recent study of the uterine circulation in 
women with a previous CD has shown that the uterine vascular resistance is increased, 
whilst the volume blood flow is decreased, compared to women with a previous vaginal 
birth.29 These data suggest that the blood circulation around the scar is impaired. Poor 
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vascularization of the scar area may lead or contribute to permanent focal myometrial 
degeneration, as well as reduced or absent re-epithelialisation of the scar area. 
Prior CD, and in particular prior pre-labor CD, are associated with a two-fold 
increase in the risk of placenta previa in subsequent pregnancies.30 Only 4.1% of 
women with one prior CD presenting with a placenta previa will also have a PAS31, 
demonstrating that normal implantation can occur over scar tissue. A caesarean scar 
pregnancy is the implantation of a sonographically detectable gestational sac into a 
uterine scar. It has been suggested that a scar pregnancy is not a separate entity from 
PAS, but rather a continuum of the same condition.32,33 However, not all scar 
pregnancies require major surgery or life-saving hysterectomy at the time of delivery,34 
suggesting that in some cases the scar defect can be large enough to host an entire 
gestational sac without the villi of the definitive placenta implanting deep into the 
remaining myometrium or into the uterine serosa. This also suggest that if the 
gestational sac implants by the side of a CD scar this may lead to focal accreta 
placentation with no clinical symptoms in early pregnancy allowing the pregnancy to 
continue in the second trimester without being diagnosed as PAS.  
Overall, these data support the concept that macroscopic and/or microscopic 
disruptions to the uterine cavity inflict permanent damage to the endometrio-myometrial 
interface. This damage has a primary impact on the biology of the scar area creating 
conditions for preferential attachment of the blastocyst to the scar tissue as well as a 
secondary impact on decidualization of the endometrium around the scar. The absence 
of decidua in first-trimester cases of PAS35 refutes previous suggestions that the 
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decidual layer is normal at the beginning of gestation and atrophies as pregnancy 
progresses. 
 
Scar placentation  
Human placentation is almost unique amongst mammals in that it is physiologically 
highly invasive. Soon after implantation, mononuclear cytotrophoblast cells proliferate at 
the tips of anchoring villi, and form columns of cells that merge together to form the 
cytotrophoblastic shell that encapsulates the conceptus.36,37 Those cells on the outer 
surface that make contact with the decidua undergo a partial epithelial-mesenchymal 
transition, lose their proliferative potential, and invade the decidual stroma. These cells 
are collectively called extravillous trophoblast (EVT). They differentiate primarily into 
interstitial and endovascular sub-populations that migrate through the decidual stroma 
and down into the lumens of the spiral arteries respectively. Interstitial EVT invade the 
uterine wall as far as the inner third of the uterine myometrium, where they fuse to form 
multinucleated trophoblast giant cells (MNGCs).38 This area is known as the junctional 
zone (JZ).37 Migration of the EVT is facilitated by their secretion of a variety of matrix 
metalloproteinases (MMPs) comprising collagenases, gelatinases and stromelysins.4 
During normal migration these enzymes break down the extracellular matrix between 
the decidual cells, but can equally well digest scar tissue if implantation overlies a 
myometrial lesion.  
 In accreta placentation, EVT cells invade the uterine wall to a greater depth, are 
hypertrophic, and their numbers are increased whereas the number of MNGCs is 
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reduced.39-41 It is not clear from these observations whether the EVTs are genuinely 
hyperplastic since cell densities rather than total numbers have been reported. In PAS, 
the proliferative index and apoptotic rate are similar to normally implanted placentas and 
so it may be that the normal number of EVTs is packed into a smaller volume of 
decidua. Deeper trophoblast invasion of the myometrium and infiltration of chorionic villi 
into myometrial vascular spaces has been recently documented in both PI and PP.42 
These events lead to an absence of the normal plane of cleavage above the decidua 
basalis, thus, preventing placental separation after delivery in cases of PAS (Figure 5). 
Deeper placental tissue invasion may not be due to a further invasion of EVT in the 
uterine wall. This may arise secondary to dehiscence of a scar, possibly under the 
actions of MMPs, leading to the presence of chorionic villi deep within the uterine wall, 
and thus giving EVTs greater access to the deep myometrium (Figure 4). Overall, 
superficial damage, such as after a curettage, or distortion of the deciduo-myometrial 
layer, such as with a sub-mucous fibroid, will probably lead to mainly superficial 
abnormally adherent placentation. This possibly explains the very rare cases of PAS 
which have been reported in primiparous women.3-5  
Stronger labelling of the villous syncytiotrophoblast for epidermal growth factor 
receptor (EGFR) has been observed in PAS compared to normal pregnancies43-45, 
suggesting that abnormal villous adherence develops as a result of aberrant expression 
of growth-, angiogenesis- and invasion-related factors in trophoblast populations. 
However, there was no change in staining intensity for the EVT, and the functional 
significance of differences in receptor expression between the syncytiotrophoblast, 
which has no invasive capacity, and the invasive EVT in PAS is difficult to interpret. 
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Increased vascular endothelial growth factor (VEGF) and phosphotyrosine 
immunostaining has also been observed in EVT cells from placenta previa accreta.46 
These cells also co-expressed vimentin and cytokeratin-7, an epithelial-to-mesenchymal 
transition feature and tumor-like cell phenotype.46 One of the mechanisms proposed by 
which EVTs lose their invasive phenotype is through syncytial-type fusion into 
MNGCs.35 More recently, lower immunostaining for soluble fms-like tyrosine kinase 
(sFLT-1), which is a potent antiangiogenic growth factor, has been found in the EVT 
cells in cases of of PAS47. These findings suggest that VEGF and sFLT-1 play a pivotal 
role in the pathological programming of EVTs toward increased motility and 
invasiveness in PAS. The cellular changes in the trophoblast observed in PAS are 
probably also secondary to the unusual myometrial environment in which it develops. In 
particular, to the loss of the physiological utero-placental oxygen gradient can have a 
direct impact on the cytotrophoblastic differentiation patterns.48,49 There may also be 
differences in the local populations of maternal immune cells that interact with the EVT, 
notably the uterine Natural Killer (uNK) cells that release cytokines regulating invasion.50 
Overall, these findings emphasise the role of the decidua in modulating 
placentation. Its replacement by scar tissue results in secondary dysfunctional 
decidualization and trophoblastic over-invasiveness in PAS. There is no firm evidence 
of a primary trophoblastic biological defect in any of the different grades of PAS, unlike 
those observed in placental insufficiency and hydatidiform moles. 
 
Vascular remodelling 
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The uterine arteries provide the main blood supply to the uterus.51 They give rise to the 
arcuate arteries which in turn give rise to the radial arteries that are directed towards the 
lumen of the uterus. As they reach the JZ, each radial artery gives off lateral branches, 
the basal arteries, that supply the myometrium and the deeper basalis part of the 
endometrium. The vessel then continues as a spiral artery. Each spiral artery gives off 
small branches supplying the capillary plexus surrounding the uterine glands. In the 
non-pregnant state, the walls of the spiral and radial arteries contain large quantities of 
smooth muscle equipped with a rich autonomic innervation which makes them highly 
responsive to both exogenous and endogenous adrenergic stimuli.49 
In normal placentation, EVT cells penetrate the JZ via the action of their 
proteases on the intercellular ground substance, affecting its mechanical and 
electrophysiological properties. The structure and properties of the walls of the spiral 
arteries are also changed.37 The remodelling of the arteries is characterized by the 
progressive loss of myocytes from their media and their internal elastic lamina, which 
are replaced by fibrinoid material. Consequently, these vessels lose their 
responsiveness to circulating vasoactive compounds and become a low-resistance 
vascular network through dilatation.49 This transformation, termed "physiological 
changes", results in the metamorphosis of small calibre spiral vessels into flaccid 
distended arteries with a 5-10-fold dilation at the vessel mouth (Figure 3). This dilatation 
is generalised, but non-uniform with considerable variation in size between arteries 
within the same specimen, and even at different points along individual arteries.49 The 
terminal coils of the spiral arteries are extremely dilated, often reaching 2-3 mm in 
diameter which represents an approximately 4-fold increase in the diameter of the 
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vessel at the myometrial-endometrial boundary and within the distal myometrium.49 
Around 30-50 spiral arteries are transformed during the first and early second 
trimesters. In normal pregnancies transformation of these utero-placental arteries is 
completed around mid-gestation.51 By contrast, the segment just below the JZ 
represents the limit of physiological trophoblast invasion and the radial and arcuate 
arteries remain highly vaso-reactive throughout pregnancy.49 
If the numbers of interstitial EVTs are increased in PAS, spiral artery remodeling 
has been described as reduced, more so in cases of PAS without local decidua.41,52 
Decidua is sometimes completely absent in the accreta area,52 probably due to atrophy 
of the uterine circulation within the scar area in non-pregnant women with prior CD.29 
There is no clinical evidence of utero-placental insufficiency and impairment of fetal 
growth associated with any of the different grades of PAS. This is in contrast with the 
reduction in trophoblast invasion and failure of conversion of the spiral arteries which is 
observed in complications of pregnancy, such as preeclampsia and fetal growth 
restriction. This suggests that in both abnormally adherent and invasive placentation the 
incomplete remodelling of the spiral arteries is limited to the accreta area without 
impacting entire placental function. Another possible hypothesis is that in the absence 
of a decidua, the normal release of proteases and cytokines from activated maternal 
immune cells is missing, impairing arterial remodelling focally.  
In cases of invasive placentation, an unusual uteroplacental vasculature has 
been observed in which physiological changes were present in large arteries deep in 
the myometrium.52 Invasion of larger vessels beyond the level of the JZ is probably 
determined by access rather than a pre-existing defect in trophoblastic differentiation 
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that would produce uncontrolled invasion of EVT through the entire depth of the 
myometrium.35 Prenatal imaging and macroscopic observation at delivery of the 
hypervascularity of the placental bed in most cases of invasive placentation suggest a 
phenomenon of neovascularisation around the scar area in addition to the 
vasodilatation of the radial and/or arcuate uterine vasculature in the accreta area. 
 
ULTRASOUND CHANGES SEEN IN PAS 
A wide variety of different medical and non-medical terms have been used to describe 
placental lesions on ultrasound since the first description of a complete hydatidiform 
mole by MacVicar and Donald in 1963.53 The ultrasound features of PAS were 
essentially described by Finberg and Williams54 for grey-scale and by Chou et al55,56 for 
color Doppler imaging (CDI), and both have been used by many authors of subsequent 
cases reports and cohort series.18 Very few authors have reported on the use of 
transvaginal sonography (TVS) in PAS outside the location and follow-up of placenta 
praevia accreta.57 Thus, most case reports and cohort studies have described 
ultrasound images obtained transabdominally from PAS diagnosed in the late second 
and early third trimesters. This, and the fact that the resolution of ultrasound imaging 
has improved over the last three decades, may explain the wide variation in terminology 
used to describe the prenatal ultrasound features associated with PAS.  
In 2016, The European Working Group on Abnormally Invasive Placenta (EW-
AIP) proposed standardized descriptions of ultrasound signs used for the prenatal 
diagnosis of PAS58, the pathophysiology of which we have analyzed below: 
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Loss of the ‘clear zone’: is used when the normal hypoechoic retroplacental zone in 
the myometrium under the placental bed is not visible on ultrasound. It was one of the 
first signs identified by grey-scale ultrasound imaging in cases of PAS.59,60 This sign is 
supposed to represent an abnormal extension of the placental villi through the decidua 
basalis into the myometrium and has been used by many authors as a marker of PAS 
on grey-scale ultrasound.18  
 The anatomy of the placental bed changes with advancing gestation. At the end 
of the first trimester, when the definitive placenta is fully formed it is made of 2 layers i.e. 
a thick decidua containing numerous glands and the terminal coils of spiral arteries and 
the superficial myometrium containing the basal arteries. As pregnancy advances, the 
decidual layer becomes thinner and discontinuous (Figure 5) and the myometrium will 
also become thinner and more heterogeneous due to the progressive dilatation of the 
utero-placental circulation. These layers generate an echolucent ultrasound signal 
under the placenta (Figure 6). 
Loss of the clear zone has been reported in around 70% of cases in those series 
that have included data on the depth of villous myometrial invasion.18 Some authors 
have found that this sign is not accurate for the diagnosis of PAS as its appearance will 
vary with advancing gestation.61,62 In addition, it will also change with the location of the 
placenta inside the uterine cavity, direct pressure of the ultrasound probes and/or the 
filling of the bladder (Figures 6 and 7) and may be obscured by the amount of scar 
tissue present. 
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Myometrial thinning: to <1mm or to where the myometrium becomes undetectable on 
ultrasound, has been used a prenatal diagnostic sign for PAS63-66 but it is only reported 
in 50% of the cohort studies.18 This can be seen when the placenta develops 
underneath a major scar defect, where the myometrium is thinner than normal or 
completely replaced by scar tissue. In this case, the myometrium will become thinner 
with advancing gestation independently of any abnormal villous invasion. This thinning 
effect is more pronounced in the third trimester, in particular after 32-34 weeks when the 
lower uterine segment is further stretched by the combined action of the fetal 
presentation and Braxton-Hicks uterine contractions. This may contribute to false 
positive diagnoses where extreme myometrial thinning is incorrectly diagnosed as 
abnormal invasion. Occasionally, the myometrium may partly dehisce or become so thin 
that the placenta can be seen through it at delivery; this phenomenon should be 
described as a ‘uterine window’ (Figure 8) as it represents deficient myometrium rather 
than abnormal placentation.  
In true PAS, especially PP, the myometrium appears excessively thin or 
undetectable due to villous invasion. This not only results in the loss of the clear zone 
but also changes the echogenicity of the myometrium itself, resulting in a loss of visual 
contrast between placental tissue and myometrium. In invasive placentation, as the villi 
breach the serosa, the myometrial echogenicity becomes indistinguishable from that of 
the placental tissue (Figure 9). The sonographer must take care with this sign as like the 
clear zone, myometrial thickness will also be influenced by direct pressure of the 
ultrasound probes, and the fullness of the maternal bladder.  
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Placental lacunae: are numerous, large, irregular sonolucent intra-placental spaces 
often described on ultrasound5,54,60,61 giving the placenta a “moth-eaten” appearance in 
PAS in both transabdominal (Figure 10) and transvaginal (Figure 11) ultrasound. It is 
the most common ultrasound sign described in PAS with around 80% of the authors 
reporting them antenatally, independently of the depth of invasion.18 Other terms have 
been used to describe these spaces including “placental lakes” 6,55,67 and “Swiss 
cheese”.67,68  
Placental lakes are seen as echolucent areas often in the centre of a lobule or 
cotyledon (Figure 12), under the chorionic plate or in the marginal zone. These lakes 
are a common finding in normal pregnancies from the end of the first trimester but 
changes in their peripheral echogenicity (resulting in the term echogenic cystic lesions) 
has been associated the development of intervillous thrombosis69 and utero-placental 
insufficiency.70,71 The shape and number of lakes will vary with gestational age, with the 
location of the placenta inside the uterine cavity and with direct pressure of the 
ultrasound probes (Figure 12). 
The difference between the lacunae associated with abnormal invasion and 
placental lakes is not clear cut, but relates to number, shape, location and velocity of the 
blood flow inside the space. Finberg attempted to classify these features, with grade 3 
representing the lacunae seen with invasive placentation.54 The lacunae are often 
numerous in one part of the placenta, large and irregular in size. They develop 
secondary to the distortion of the anatomy of one or more cotyledons including an inter-
lobular septa3 due to the arrival of high velocity (peak systolic velocity often >10 cm/sec) 
maternal blood from a radial or arcuate artery (Figure 13).72 Placental lakes may also 
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arise secondary to the presence of a larger than average feeder vessel supplying an 
increased blood flow volume to the lobule (Figure 13), thus focally distorting its 
anatomy, but the impact on the cotyledon is less pronounced as the vessel involved is a 
spiral artery (Figure 3). However, in normal placentation, it is unlikely that there will be 
many such vessels resulting in fewer lakes and the underlying myometrium is of normal 
thickness. Both lacunae and lakes become more prominent from the end of the first 
trimester when the intervillous circulation is established48,49 and will change in size and 
shape as pregnancy advances. 
By contrast, the “Swiss cheese” transformation of the placenta describes the 
cystic hydropic changes of the villi found in a partial hydatidiform mole.73 These lesions 
are smaller and distributed at random within the placental structure. They never contain 
a fetal circulation and thus the “Swiss cheese” terminology should not be used to 
describe the vascular lacunae found in PAS. 
 
Bladder wall interruption: often described on grey-scale ultrasound as an interruption, 
loss or irregularity of the bladder wall or of the hyperechoic line between uterine serosa 
and bladder lumen.54,74 This sign may arise as a direct result of villous invasion into the 
muscle of the posterior wall of the bladder, thereby changing its echogenicity, but is 
most likely an ultrasound artefact arising from the massive neovascularity found within 
the peritoneal fold between the anterior wall of the uterus and the posterior wall of the 
bladder (Figure 14).  Insonation of the walls of the numerous tangled vessels disrupts 
the flat surface required to provide the bright straight line usually seen resulting in the 
apparent interruptions. 
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Care must be taken by the sonographer to ensure that the break seen in the 
bright line representing the posterior bladder wall is a genuine area of echolucency and 
not artefact as a result of ultrasound dropout from the angle of insonation. 
 
Placental bulge: describes the ‘ballooning’ of the uterus containing the placenta away 
from its expected plane into the surrounding tissue, usually the bladder. This sign is 
seen on ultrasound (Figure 14) and MRI imaging. It most likely represents villous 
invasion deep into and/or through the myometrium resulting in loss of structural integrity 
of the surrounding uterine muscle. The placenta will then ‘bulge’ outwards into 
surrounding structures. This phenomenon is seen at laparotomy and has been 
described as the ‘snowman sign’.75  
  
Exophytic mass: describes the invasion of the villous tissue through the myometrium 
and the serosa into adjacent extrauterine organs, usually the bladder. This focal 
exophytic mass of placental tissue, extending beyond the uterine serosa should only 
occur in cases of PP. In case reports and cohort studies that provide detailed data on 
the depth of invasion, bladder wall interruption, bladder bulge and exophytic mass are 
collectively reported in 33% of the cases of invasive placentation.18 
 
Sub-placental and/or utero-vesical hypervascularity: resulting from excessive 
dilatation of the utero-placental circulation beyond the spiral arteries i.e. including the 
radial and arcuate arteries, is a prominent feature of PAS on prenatal 
ultrasound.18,55,56,74,76-79 This is often accompanied by extensive neovascularization 
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within the peritoneum, especially between the anterior wall of the uterus and the 
posterior wall of the bladder.  
The use of CDI (Figures 10 and11) has enabled visualization of the utero-
placental circulation in greater detail; up to 81% of the cases of PI and 75% of the cases 
of PP present with hypervascularisation patterns within or under the placental bed (the 
subplacental zone).18 In addition, vessel distributions are more heterogeneous in PI with 
the size and spatial organization of the PI vascular architecture at the utero-placental 
interface differing from normal placentation.79 A combination of sonography, vascular 
casting and oxygen measurements has shown that an extensive network of arterio-
venous shunts normally exist within the myometrium in the placental bed.80 Villous 
invasion into these deep shunts may partly explain the persistence of significant blood 
flow after delivery in PAS81 as well as differences seen in vessel distribution, size and 
spatial organisation in the placental bed area. Invasion into these shunts is the 
proposed cause of the large areas of abnormal vascular confluence seen with 3D power 
Doppler imaging in cases of PP.76 In addition, the vasculature characteristics of the 
placental bed may vary in PAS depending on the position of the placenta inside the 
uterine cavity, whether near to or far from the main uterine arteries, and on the 
remodelling of the myometrial circulation around the scar area.  Thus, like the placental 
bed, myometrial thickness and lacunae, the vascular features under and around the 
accreta area will change with advancing gestation. 
 
Placental lacunae feeder vessels:  seen as vessels with high velocity blood flow 
arising from the deep arterial vasculature of the myometrium i.e. radial or arcuate 
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arteries and feeding the lacunae (Figure 13). An ultrasound study has found that the 
total area occupied by vessels in normal and PI placental beds is similar, but that 
vessels are significantly sparser and larger in invasive placentation.79 This could explain 
the abnormal haemodynamics underlying the development of the lacunae in invasive 
placentation. 
 
Bridging vessels: are seen as CD signals arising in the myometrium and appearing to 
travel beyond the uterine serosa and into the bladder before disappearing (Figure 14). 
This ‘bridging’ is an ultrasound artefact as these vessels do not traverse between the 
myometrium and the bladder but are actually the contorted vessels of the neovascularity 
within the peritoneum caught in cross-section in a 2D image (Figure 14). They have 
been referred to as “bladder varicosities” in cases of placenta previa accreta.77, 78  
Collectively, these CDI features have been reported in 66% of the cases of AIP 
diagnosed prenatally18, and are due to the dilatation of large and deeper myometrial 
vessels below the JZ of normal implantation.  
 
PATHOLOGICAL CORRELATIONS 
Many imaging cohort studies on PAS do not include a histopathological confirmation, or 
when they do it is limited to a brief description of the number of cases that were 
examined without a precise description of the extension of the abnormal placental 
attachment, degree of invasion and/or spatial relationship of the accreta villous tissue 
with the previous CD scar, cervix, main uterine circulation etc. In a recent systematic 
review, we found that detailed correlations between ultrasound findings and accreta 
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grading of a delivery were only reported in 34 out of 1078 cases18, although more than 
90% of the cases had a caesarean hysterectomy or a secondary hysterectomy after a 
failed attempt at conservative management. This limits the correlation between prenatal 
ultrasound features and clinical evidence at the time of delivery. This will also lead 
inevitably to false positive diagnosis of PAS in many cases, in particular when the 
surgeon is able to remove the placenta manually and the bleeding is secondary to 
uterine atonia and not to damage of the myometrial circulation, or when the placenta is 
praevia and there is a scar dehiscence with placental tissue visible through the uterine 
serosa.  
The first histopathological series of PA by Irving and Hertig included only cases 
of abnormal adherence.1 All of their 18 cases presented clinically as “failure of the 
placenta to separate” and 14 required a secondary hysterectomy to control the 
bleeding. In seven cases, the obstetrician was able to remove the placenta manually 
and in three cases the retained villous tissue was removed by curettage. None of their 
cases of hysterectomy with placenta “in situ” presented with macroscopic evidence of 
an excessive dilatation of the radial and arcuate circulation, and in all cases the 
diagnosis was made exclusively on the histological finding of “complete or partial 
absence of the decidua with villi directly embedded in the myometrium”. Only one of 
their patients (case 12) had a prior CD, and the only different pathological finding in that 
case was that the scar area where the placenta was attached was thinner than the rest 
of the uterine wall. All their remaining patients had a history of manual removal, 
curettage and/or endometritis, suggesting that minor traumas and/or chronic 
inflammation can lead an abnormally adherent placenta in the next pregnancy. On one 
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occasion, they found on microscopic examination “an increased number of dilated veins 
in the superficial layers of the myometrium”. Similarly, out the 86 cases of PAS included 
in their literature review up to 1935, there were 19 cases of previous manual removal of 
the placenta, 10 cases of previous curettage, three cases of endometritis and only one 
case of prior CD.1  
Until the 1970s, the diagnosis of PAS was almost exclusively histological2,3,82,83 
and only very rare cases of placenta increta and percreta were reported in the literature 
before that period, and without evidence of obvious macroscopic uterine vascular 
changes.84-86 Lukes et al2, were the first to highlight the need to differentiate between 
abnormally adherent and abnormally invasive placentas, and suggested to use the 
“adherent or invasive placenta” to describe the over-all group of PAS. Modern 
pathological studies have also shown that the lateral extension of a PAS can vary and 
be focal, partial or total according to the number of accreta lobules involved.2-5 They 
have also shown that the degree of villous adhesion or invasion is rarely uniform across 
the placental bed and that many cases of PAS have creta and increta areas (Figure 2). 
The fact that accreta placentation can be heterogeneous may explain why no 
ultrasound sign, or combination of ultrasound signs, has so far been found to be specific 
of the depth of accreta placentation and accurate for the differential diagnosis between 
adherent and invasive placentation.  
Attempts at manual removal of the placenta can distort the spatial relationship 
between the accreta villous tissue and the uterine wall.2 This may limit in some cases 
the accuracy of the microscopic diagnosis, in particular, if the histological examination of 
the utero-placental interface is incomplete.2-5 Macroscopic changes in the radial/arcuate 
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circulation may not always be obvious to the pathologist as the vasculature will collapse 
during the hysterectomy procedure. The decidual layer becomes thinner and 
discontinuous with advancing gestation (Figure 5), and this can also make the 
microscopic diagnosis of adherent placenta difficult in particular if the accreta area of 
the myometrium is not extensively sampled.2 Dannheim et al87 have recently proposed 
methods of gross dissection, microscopic examination and reporting of hysterectomy 
specimens containing PAS. Their protocol facilitates retrospective correlation with 
surgical and imaging findings as well as standardized tissue sampling for potential 
research. It is essential that similar protocols are used to improve not only the diagnosis 
but also the management of the PAS. 
 
Conclusions 
Placenta accreta spectrum is a histopathologic term that defines abnormally adherent 
and invasive placentation. Both are the consequence of a deciduo-myometrial disorder, 
and the trophoblastic changes of accreta placentation are probably secondary to their 
migration beyond the JZ and their exposure to a different biological environment. This 
loss of control by the decidua of trophoblast invasion and spiral artery remodelling gives 
the extravillous trophoblast greater access to the deep myometrium and its circulation. 
The depth of penetration of the villous tissue is likely to be related to the extent of the 
deciduo-myometrial damage. Microscopic damage secondary to manual removal, 
uterine curettage and endometritis are more likely to lead to superficial adherent 
placentation. By contrast, a surgical scar defect is associated with both the absence of 
 25 
endometrial re-epithelialization of the scar area and vascular remodeling around the 
scar area and favors the development of invasive placentation.  
In the adherent placenta, the chorionic villi are in direct contact with the 
myometrium with no obvious plane of cleavage. The clinical differential diagnosis 
between an abnormally adherent placenta and a retained placenta can be difficult if the 
placenta is only partially adherent. In invasive placentation, the placental villi penetrate 
deeply within the uterine wall, including in the myometrial circulation, and cannot be 
removed manually and/or by curettage. With the exponential increase of CD around the 
world and also with increasing maternal age and the need for artificial reproductive 
techniques and minor uterine surgical procedures, the number of PAS cases, and in 
particular invasive placentation, will continue to increase.   
Ultrasound signs of adherent and invasive placentation vary with gestational age, 
and depend on the thickness and composition of the placental bed, prior scar defects, 
depth of invasion and the lateral extension of the villous tissue. Abnormal adherence 
and invasion may co-exist in the same placental bed, and thus accurate correlation of 
pathological and clinical findings with the imaging is essential. It is therefore necessary 
that these protocols are standardised and used by both clinicians and pathologists to 
improve the diagnostic accuracy of ultrasound imaging and to define ultrasound signs 
that may be useful in the screening of women at high risk of PAS. 
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Figure legends 
Fig 1: Diagram showing an anterior placenta previa on a caesarean scar and the 
different grades of placenta previa accreta: Creta (PC) where placental (P) villi adhere 
to the myometrium (M), Increta (PI) where the villi invade the myometrium and Percreta 
(PP) where the villi invade the entire myometrium and cross the uterine serosa (S). 
 
Fig 2: Diagram showing an anterior placenta previa accreta combining areas of 
abnormal adherence and invasion: Creta (PC), Increta (PI) and Percreta (PP). D= 
Decidua; M= myometrium; S= Serosa. 
 
Fig 3: Diagram showing a placental cotyledon in normal placentation (A) and increta 
placentation (B) reaching the deep myometrial circulation. Note that distortion of the 
normal cotyledon anatomy in the increta placentation with the loss of the inter-cotyledon 
septa and formation of a lacuna (L).  
 
Fig 4: Microscopic view of the placental bed from a hysterectomy specimen at 34 
weeks in a pregnancy complicated by placenta previa increta (H&E x 4) showing the 
disruption of the decidua (D) by placental villi (PV) and the very thin myometrium (M). 
 
Fig 5: Microscopic views of the placental bed from hysterectomy specimens with 
placenta in-situ (Boyd collection, The Centre for Trophoblast Research, University of 
Cambridge): A: Specimen H1094 CRL 73 mm showing a thick decidua (D) between the 
placental villi (PV) and the myometrium (M) (H&E x 2.5); B and C: Specimen H751 CRL 
260 mm. The decidua is much thinner (H&E x 2.5) and absent in some areas (Reticulin 
x 10). Scale bar (A and B) = 0.5 mm, C = 0.1 mm. 
 
Fig 6: Transabdominal ultrasound longitudinal views of the same part of a placental bed 
of a low-lying placenta at 32 weeks using exactly the same machine settings.  A: Full 
bladder and minimal probe pressure; B: Full bladder with increased probe pressure; C: 
Empty bladder and minimal probe pressure. 
 
Fig 7: Transabdominal ultrasound longitudinal views of the placental bed at 34 weeks in 
a pregnancy after 3 prior caesarean sections showing the changes on the clear zone 
(arrows) with probe pressure (right). 
 
Fig 8: Myometrial thinning secondary to uterine thinning at a scar defect. A: 
Transabdominal ultrasound longitudinal view of a placenta previa at 36 weeks showing 
a myometrium defect (arrow). Note the absence of the clear zone and myometrium in 
the area. B: Findings at surgery later the same day of a ‘uterine window’ (arrow). 
 
Fig 9: Myometrial thinning (arrows) secondary to abnormally invasive placenta. A: 
Transabdominal ultrasound longitudinal view of a placenta previa at 36 weeks showing 
no clear zone or myometrium detectable. B: Findings at surgery later the same day 
showing the myometrial distension over the accreta area. 
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Fig 10: Transabdominal ultrasound longitudinal views of a placenta previa accreta at 36 
weeks showing: A. “moth eaten” area with numerous lacunae of different size and 
shape secondary and B. high velocity, turbulent blood flow within the lacunae on CDI. 
 
Fig 11: Transvaginal ultrasound views of a placenta previa increta at 20 weeks 
showing: A. “moth eaten” appearance of the placenta with numerous lacunae of 
different size and shape secondary and B. high velocity, turbulent blood flow within the 
lacunae on CDI. 
 
Fig 12: Transabdominal ultrasound longitudinal views of placental lakes in pregnancies 
with no surgical history and no placenta accreta at birth. A. Centro-cotyledon lake at 33 
weeks with minimal probe pressure (left) and increased probe pressure (right). B. 
Multiple irregular lakes mimicking a “moth eaten” appearance similar to that seen in 
invasive placentation. 
 
Fig 13: Transabdominal ultrasound longitudinal views of placenta showing: A. Placenta 
previa accreta at 20 weeks with a feeding artery from the arcuate circulation entering a 
lacuna and B. Centro-cotyledon lake and corresponding feeder spiral artery at 28 weeks 
of gestation in an uncomplicated pregnancy. 
 
Fig 14: Placenta previa accreta. Transabdominal ultrasound longitudinal views at 28 
weeks showing: A. bladder bulge demonstrating bladder wall interruption (arrow) and B. 
bridging vessels (arrows) on CDI; C. Findings at surgery at 34 weeks showing the 
extensive neovascularity and myometrial distension over the increta area. 
 
 
 
Figure	1:	Diagram	showing	an	anterior	placenta	previa	on	a	caesarean	scar	and	the	different	grades	of	
placenta	previa	accreta:	Creta (PC)	where	placental	(P)	villi	adhere	to	the	myometrium	(M),	Increta	(PI)	
where	the	villi	invade	the	myometrium	and	Percreta	(PP)	where	the	villi	invade	the	entire	myometrium	
and	cross	the	uterine	serosa	(S).
Figure	2:	Diagram	showing	an	anterior	placenta	previa	accreta	combining	areas	of	abnormal	adherence	and	
invasion:	Creta (PC),	Increta	(PI)	and	Percreta	(PP).	D=	Decidua;	M=	myometrium;	S=	Serosa.
Figure	3:	Diagram	showing	a	placental	cotyledon	in	normal	placentation	(A)	and	increta	placentation	(B)	reaching	
the	deep	myometrial	circulation.	Note	that	distortion	of	the	normal	cotyledon	anatomy	in	the	increta	placentation
with	the	loss	of	the	septa	and	the	formation	of	a	lacuna	(L).	
L
Figure	4:	Microscopic	view	of	the	placental	bed	from	a	hysterectomy	specimen	at	34	weeks	in	a	pregnancy	
complicated	by	placenta	previa	increta	(H&E	x	4)	showing	the	disruption	of	the	decidua	(D)	by	placental	villi	
(PV)	and	the	very	thin	myometrium	(M).
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Figure	5:	Microscopic	views	of	the	placental	
bed		from	hysterectomy	specimens	with	
placenta	in-situ	(Boyd	collection,	The	Centre	
for	Trophoblast	Research,	University	of	
Cambridge):	A:	Specimen	H1094	CRL	73	mm	
showing	a	thick	decidua	(D)	between	the	
placental	villi	(PV)	and	the	myometrium	(M)	
(H&E	x	2.5);	B	and	C:	Specimen	H751	CRL	
260	mm.	The	decidua	is	much	thinner	(H&E	
x	2.5)	and	absent	in	some	areas	(Reticulin x	
10).	Scale	bar	(A	and	B)	=	0.5	mm,	C	=	0.1	
mm.
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Figure	6.	Transabdominal	ultrasound	longitudinal	views	of	the	same	part	of	a	placental	bed	of	a	low-lying	placenta	at	
32	weeks	using	exactly	the	same		machine	settings.		A:	Full	bladder	and	minimal	probe	pressure;	B:	Full	bladder	with	
increased	probe	pressure;	C:	Empty	bladder	and	minimal	probe	pressure.
Clear	zone
Figure	7:	Transabdominal	ultrasound	longitudinal	views	of	the	placental	bed	at	34	weeks	in	a	pregnancy	after	3	prior	
caesarean	sections	showing	the	changes	on	the	clear	zone	(arrows)	with	probe	pressure	(right)	.
Figure	8:	Myometrial	thinning	secondary	to	uterine	thinning	at	a	scar	defect.	A:	Transabdominal	ultrasound	longitudinal	
view	of	a	placenta	previa	at	36	weeks	showing	a	myometrium	defect	(arrow).	Note	the	absence	of	the	clear	zone	and	
myometrium	in	the	area.	B:	Findings	at	surgery	later	the	same	day	of	a	‘uterine	window’	(arrow).
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Figure	9:	Myometrial	thinning	(arrows)	secondary	to	abnormally	invasive	placenta.	A:	Transabdominal	ultrasound	
longitudinal	view	of	a	placenta	previa	at	36	weeks	showing	no	clear	zone	or	myometrium	detectable.	B:	Findings	at	
surgery	later	the	same	day	showing	the	myometrial	distension	over	the	accreta	area.
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Figure	10:	Transabdominal	ultrasound	longitudinal	views	of	a	placenta	previa	accreta	at	36	weeks	showing:
A:	“moth	eaten”	area	(arrow)	with	numerous	lacunae	of	different	size	and	shape	secondary	
and	B:	high	velocity,	turbulent	blood	flow	within	the	lacunae	on	CDI.
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Figure	11:	Transvaginal	ultrasound	views	of	a	placenta	previa	increta	at	20	weeks	showing:	
A.	“moth	eaten”	appearance	of	the	placenta	with	numerous	lacunae	of	different	size	and	shape	
secondary	and	B.	high	velocity,	turbulent	blood	flow	within	the	lacunae	on	CDI.
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Figure	12:	Transabdominal	ultrasound	longitudinal	views	of	placental	lakes	in	pregnancies	with	no	surgical	history	and	
no	placenta	accreta	at	birth.	A.	Centro-cotyledon	lake	at	33	weeks	with	minimal	probe	pressure	(left)	and	increased	
probe	pressure	(right).	B.	Multiple	irregular	lakes	mimicking	a	“moth	eaten”	appearance	similar	to	that	seen	in	invasive	
placentation.
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Figure	13:	Transabdominal	ultrasound	longitudinal	views	of	placenta	showing:	A.	Placenta	previa	accreta	at	
20	weeks	with	a	feeding	artery	from	the	arcuate	circulation	along	the	bladder	(B)	entering	a	lacuna	and	B&C.	
Multiple	lakes	and	corresponding	feeder	spiral	artery	at	32	weeks	of	gestation	in	an	uncomplicated	pregnancy.	
The	myometrium	(M)	is	clearly	seen	in	this	case.
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Figure	14.	Placenta	previa	accreta.	Transabdominal	ultrasound	longitudinal	views	at	28	weeks	showing:	A.	bladder	
bulge	demonstrating	bladder	wall	interruption	(arrow)	and	B.	bridging	vessels	(arrows)	on	CDI;	C.	Findings	at	surgery	
at	34	weeks	showing	the	extensive	neovascularity and	myometrial	distension	over	the	increta	area.
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